[Life expectancy of erythrocytes under the influence of the cytostatic 2,3,5-tris-ethyleniminobenzoquinone-(1,4) and the anabolic methenolone enanthate].
D000477:Alkylating Agents / Q000009:adverse effects*; D000743:Anemia, Hemolytic / Q000188:drug therapy / Q000209:etiology; D000818:Animals; D001389:Azirines / Q000009:adverse effects*; D001798:Blood Proteins / Q000096:biosynthesis; D004905:Erythrocyte Aging / Q000187:drug effects; D004920:Erythropoiesis / Q000187:drug effects*; D066298:In Vitro Techniques; D008710:Methenolone / Q000494:pharmacology*; D012313:RNA / Q000096:biosynthesis; D051381:Rats; D014228:Triaziquone / Q000009:adverse effects
D000477:Alkylating Agents; D001389:Azirines; D001798:Blood Proteins; D012313:RNA; D008710:Methenolone; D014228:Triaziquone
Die Lebensdauer von Erythrocyten unter der Einwirkung des Cytostaticums 2,3,5-Tris-äthyleniminobenzochinon-(1,4) und des Anabolicums Methenolon-önanthat.